Madagascar vs Panama: Previously treated cases tested for RR-/MDR-TB
Madagascar
69.0%
in 2024
Panama
61.0%
in 2022
Madagascar rank
134th
Panama rank
136th
Previously treated cases tested for RR-/MDR-TB over time
- Madagascar
- Panama
How they compare
Madagascar currently reports 69.0% against 61.0% in Panama, a difference of 8.0%.
That makes Madagascar's figure about 1.1 times Panama's.
The two have swapped places 4 times across 14 shared years of data; in 2007 it was Panama ahead.
Madagascar ranks 134th and Panama ranks 136th of 180 countries.
Across the 3 decades both report, Madagascar averaged higher in 1 and Panama in 2.
Head to head by decade
| Decade | Madagascar | Panama | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.5% | 4.3% | 0.1% | Madagascar |
| 2010s | 18.3% | 32.6% | 14.4% | Panama |
| 2020s | 54.0% | 64.5% | 10.5% | Panama |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Madagascar or Panama?
- Madagascar, at 69.0% against 61.0% in Panama as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Madagascar and Panama?
- 8.0%, with Madagascar ahead.
- How many years of comparable data are there for Madagascar and Panama?
- 14 years are reported by both, from 2007 to 2022.
- How do Madagascar and Panama rank globally for previously treated cases tested for rr-/mdr-tb?
- Madagascar ranks 134th and Panama ranks 136th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.